<ul>
<li>3 只潛力巨大的低於 20 美元的股票</li>
</ul>
<p>Bioceres Crop Solutions Corp.（NASDAQ:BIOX - 免費報告）- Brookline Capital Management 的投資分析師在 9 月 9 日（星期二）發佈的研究報告中下調了 Bioceres Crop Solutions 的 2026 財年每股收益預期。Brookline Capital Management 的分析師 K. Dolliver 現在預計該公司將在本年度發佈每股收益為（$0.12），低於之前的預期$0.21。Brookline Capital Management 目前對該股票的評級為 “持有”。市場普遍預計 Bioceres Crop Solutions 當前全年的每股收益為（$0.05）。</p>
<p>其他幾位股票分析師最近也對 BIOX 發佈了報告。華爾街 Zen 在 8 月 31 日（星期日）的一份報告中將 Bioceres Crop Solutions 的評級從 “賣出” 上調至 “持有”。Canaccord Genuity Group 重申了 “持有” 評級，並在週三對 Bioceres Crop Solutions 的股票發佈了$2.50 的目標價（之前為$6.50）。Lake Street Capital 在週三的研究報告中將 Bioceres Crop Solutions 的目標價從$8.00 下調至$5.00，並對該公司給予了 “買入” 評級。最後，Oppenheimer 在週二的研究報告中對 Bioceres Crop Solutions 的股票設定了$5.00 的目標價。兩位研究分析師對該股票給予了 “買入” 評級，兩位則給予了 “持有” 評級。根據 MarketBeat.com 的數據，該股票目前的共識評級為 “適度買入”，共識目標價為$4.17。</p>
<p><strong>獲取我們關於 BIOX 的最新報告</strong></p>
<h2>Bioceres Crop Solutions 價格表現</h2>
<p>BIOX 的股票在週五開盤價為$2.09。Bioceres Crop Solutions 的 12 個月低點為$1.97，12 個月高點為$8.93。該公司的債務與股本比率為 0.22，流動比率為 1.02，速動比率為 0.74。該股票的 50 日移動平均價格為$3.32，200 日移動平均價格為$4.10。該公司的市值為$1.3106 億，市盈率為-2.58，PEG 比率為 0.88，貝塔值為 0.43。</p>
<h2>機構投資者對 Bioceres Crop Solutions 的看法</h2>
<p>機構投資者最近買入和賣出了該股票的股份。Jones Financial Companies Lllp 在第一季度將其在 Bioceres Crop Solutions 的持倉增加了 3535.8%。Jones Financial Companies Lllp 現在擁有 5,490 股該公司的股票，價值$25,000，此前在上個季度又購買了 5,339 股。美國銀行在第四季度將其在 Bioceres Crop Solutions 的持倉增加了 186.8%。美國銀行現在擁有 5,735 股該公司的股票，價值$35,000，此前在上個季度又購買了 3,735 股。Northern Trust Corp 在第四季度收購了 Bioceres Crop Solutions 的新股份，價值約$93,000。Avanza Fonder AB 在第一季度購買了 Bioceres Crop Solutions 的新股份，價值約$72,000。最後，PDT Partners LLC 在第一季度購買了 Bioceres Crop Solutions 的新股份，價值約$81,000。機構投資者和對沖基金持有該公司 17.68% 的股份。</p>
<h2>關於 Bioceres Crop Solutions</h2>
<p>（獲取免費報告）</p>
<p>Bioceres Crop Solutions Corp 及其子公司提供作物生產力解決方案。它通過種子和綜合產品、作物保護和作物營養三個部門運營。種子和綜合產品部門提供種子特性、種質和種子處理包，以促進更健康和更高產的作物。</p>
<h2>瞭解更多</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Bioceres Crop Solutions</li>
<li>如何最有效地使用 MarketBeat 收益篩選器</li>
<li>接近阻力的高飛股票：3 只值得關注的股票</li>
<li>如何投資藍籌股</li>
<li>希捷科技引領標準普爾 500：其 120% 漲幅背後的原因是什麼？</li>
<li>股票平均計算器</li>
<li>先鋒集團的 VUG ETF：您投資組合的終極增長 ETF</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QklPWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QklPWA"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送至 contact@marketbeat.com。</em></p>
<h2>您現在應該投資$1,000 於 Bioceres Crop Solutions 嗎？</h2>
<p>在您考慮 Bioceres Crop Solutions 之前，您需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Bioceres Crop Solutions 並不在名單上。</p>
<p>雖然 Bioceres Crop Solutions 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

BIOX

<p>布魯克林資本管理公司的投資分析師已將 Bioceres Crop Solutions Corp.（NASDAQ:BIOX）2026 財年的每股收益預期從 0.21 美元下調至-0.12 美元。該公司對該股票維持 “持有” 評級。其他分析師也調整了他們的評級，加拿大和豐銀行將其目標價從 6.50 美元下調至 2.50 美元，而湖街資本設定的目標價為 5.00 美元。目前，該股票的共識評級為 “適度買入”，目標價為 4.17 美元</p>

<ul>
<li>3 Bargain Stocks Under $20 With Major Growth Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只潛力巨大的低於 20 美元的股票</li>
</ul>
</div><p>Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) - Investment analysts at Brookline Capital Management lowered their FY2026 earnings per share estimates for shares of Bioceres Crop Solutions in a research report issued on Tuesday, September 9th. Brookline Capital Management analyst K. Dolliver now expects that the company will post earnings per share of ($0.12) for the year, down from their previous estimate of $0.21. Brookline Capital Management currently has a &#34;Hold&#34; rating on the stock. The consensus estimate for Bioceres Crop Solutions' current full-year earnings is ($0.05) per share.</p>
<div class="lb-trans"><p>Bioceres Crop Solutions Corp.（NASDAQ:BIOX - 免費報告）- Brookline Capital Management 的投資分析師在 9 月 9 日（星期二）發佈的研究報告中下調了 Bioceres Crop Solutions 的 2026 財年每股收益預期。Brookline Capital Management 的分析師 K. Dolliver 現在預計該公司將在本年度發佈每股收益為（$0.12），低於之前的預期$0.21。Brookline Capital Management 目前對該股票的評級為 “持有”。市場普遍預計 Bioceres Crop Solutions 當前全年的每股收益為（$0.05）。</p>
</div><p>Several other equities analysts also recently issued reports on BIOX. Wall Street Zen raised shares of Bioceres Crop Solutions from a &#34;sell&#34; rating to a &#34;hold&#34; rating in a report on Sunday, August 31st. Canaccord Genuity Group reaffirmed a &#34;hold&#34; rating and issued a $2.50 price objective (down previously from $6.50) on shares of Bioceres Crop Solutions in a report on Wednesday. Lake Street Capital reduced their target price on shares of Bioceres Crop Solutions from $8.00 to $5.00 and set a &#34;buy&#34; rating for the company in a research note on Wednesday. Finally, Oppenheimer set a $5.00 target price on shares of Bioceres Crop Solutions in a research report on Tuesday. Two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $4.17.</p>
<div class="lb-trans"><p>其他幾位股票分析師最近也對 BIOX 發佈了報告。華爾街 Zen 在 8 月 31 日（星期日）的一份報告中將 Bioceres Crop Solutions 的評級從 “賣出” 上調至 “持有”。Canaccord Genuity Group 重申了 “持有” 評級，並在週三對 Bioceres Crop Solutions 的股票發佈了$2.50 的目標價（之前為$6.50）。Lake Street Capital 在週三的研究報告中將 Bioceres Crop Solutions 的目標價從$8.00 下調至$5.00，並對該公司給予了 “買入” 評級。最後，Oppenheimer 在週二的研究報告中對 Bioceres Crop Solutions 的股票設定了$5.00 的目標價。兩位研究分析師對該股票給予了 “買入” 評級，兩位則給予了 “持有” 評級。根據 MarketBeat.com 的數據，該股票目前的共識評級為 “適度買入”，共識目標價為$4.17。</p>
</div><p><strong>Get Our Latest Report on BIOX</strong></p>
<div class="lb-trans"><p><strong>獲取我們關於 BIOX 的最新報告</strong></p>
</div><h2>Bioceres Crop Solutions Price Performance</h2>
<div class="lb-trans"><h2>Bioceres Crop Solutions 價格表現</h2>
</div><p>Shares of BIOX opened at $2.09 on Friday. Bioceres Crop Solutions has a 12 month low of $1.97 and a 12 month high of $8.93. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.02 and a quick ratio of 0.74. The stock has a fifty day moving average price of $3.32 and a 200 day moving average price of $4.10. The company has a market cap of $131.06 million, a P/E ratio of -2.58, a PEG ratio of 0.88 and a beta of 0.43.</p>
<div class="lb-trans"><p>BIOX 的股票在週五開盤價為$2.09。Bioceres Crop Solutions 的 12 個月低點為$1.97，12 個月高點為$8.93。該公司的債務與股本比率為 0.22，流動比率為 1.02，速動比率為 0.74。該股票的 50 日移動平均價格為$3.32，200 日移動平均價格為$4.10。該公司的市值為$1.3106 億，市盈率為-2.58，PEG 比率為 0.88，貝塔值為 0.43。</p>
</div><h2>Institutional Investors Weigh In On Bioceres Crop Solutions</h2>
<div class="lb-trans"><h2>機構投資者對 Bioceres Crop Solutions 的看法</h2>
</div><p>Institutional investors have recently bought and sold shares of the stock. Jones Financial Companies Lllp grew its position in Bioceres Crop Solutions by 3,535.8% in the 1st quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company's stock valued at $25,000 after buying an additional 5,339 shares in the last quarter. Bank of America Corp DE raised its position in shares of Bioceres Crop Solutions by 186.8% during the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company's stock worth $35,000 after buying an additional 3,735 shares in the last quarter. Northern Trust Corp acquired a new stake in shares of Bioceres Crop Solutions in the 4th quarter worth approximately $93,000. Avanza Fonder AB bought a new position in shares of Bioceres Crop Solutions in the first quarter valued at approximately $72,000. Finally, PDT Partners LLC bought a new position in shares of Bioceres Crop Solutions in the first quarter valued at approximately $81,000. Institutional investors and hedge funds own 17.68% of the company's stock.</p>
<div class="lb-trans"><p>機構投資者最近買入和賣出了該股票的股份。Jones Financial Companies Lllp 在第一季度將其在 Bioceres Crop Solutions 的持倉增加了 3535.8%。Jones Financial Companies Lllp 現在擁有 5,490 股該公司的股票，價值$25,000，此前在上個季度又購買了 5,339 股。美國銀行在第四季度將其在 Bioceres Crop Solutions 的持倉增加了 186.8%。美國銀行現在擁有 5,735 股該公司的股票，價值$35,000，此前在上個季度又購買了 3,735 股。Northern Trust Corp 在第四季度收購了 Bioceres Crop Solutions 的新股份，價值約$93,000。Avanza Fonder AB 在第一季度購買了 Bioceres Crop Solutions 的新股份，價值約$72,000。最後，PDT Partners LLC 在第一季度購買了 Bioceres Crop Solutions 的新股份，價值約$81,000。機構投資者和對沖基金持有該公司 17.68% 的股份。</p>
</div><h2>About Bioceres Crop Solutions</h2>
<div class="lb-trans"><h2>關於 Bioceres Crop Solutions</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.</p>
<div class="lb-trans"><p>Bioceres Crop Solutions Corp 及其子公司提供作物生產力解決方案。它通過種子和綜合產品、作物保護和作物營養三個部門運營。種子和綜合產品部門提供種子特性、種質和種子處理包，以促進更健康和更高產的作物。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>瞭解更多</h2>
</div><ul>
<li>Five stocks we like better than Bioceres Crop Solutions</li>
<li>How to Most Effectively Use the MarketBeat Earnings Screener</li>
<li>High-Flyers Near Resistance: 3 Stocks to Watch for a Dip</li>
<li>How to Invest in Blue Chip Stocks</li>
<li>Seagate Technology Leads S&amp;P 500: What’s Behind Its 120% Gain?</li>
<li>Stock Average Calculator</li>
<li>Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Bioceres Crop Solutions</li>
<li>如何最有效地使用 MarketBeat 收益篩選器</li>
<li>接近阻力的高飛股票：3 只值得關注的股票</li>
<li>如何投資藍籌股</li>
<li>希捷科技引領標準普爾 500：其 120% 漲幅背後的原因是什麼？</li>
<li>股票平均計算器</li>
<li>先鋒集團的 VUG ETF：您投資組合的終極增長 ETF</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QklPWA" alt="" original-src="https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx?Prefix=NASDAQ&amp;Symbol=BIOX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Bioceres Crop Solutions Right Now?</h2>
<div class="lb-trans"><h2>您現在應該投資$1,000 於 Bioceres Crop Solutions 嗎？</h2>
</div><p>Before you consider Bioceres Crop Solutions, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考慮 Bioceres Crop Solutions 之前，您需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioceres Crop Solutions wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Bioceres Crop Solutions 並不在名單上。</p>
</div><p>While Bioceres Crop Solutions currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Bioceres Crop Solutions 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Brookline Capital Management 調低了 BIOX 2026 財年的每股收益預期